Public Employees Retirement System of Ohio maintained its stake in Fluidigm Corporation (NASDAQ:FLDM) during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 45,664 shares of the medical research company’s stock at the end of the first quarter. Public Employees Retirement System of Ohio owned 0.16% of Fluidigm Corporation worth $260,000 at the end of the most recent reporting period.
A number of other hedge funds also recently added to or reduced their stakes in FLDM. Metropolitan Life Insurance Co. NY boosted its stake in Fluidigm Corporation by 3.1% in the fourth quarter. Metropolitan Life Insurance Co. NY now owns 20,789 shares of the medical research company’s stock worth $151,000 after buying an additional 632 shares during the period. Stoneridge Investment Partners LLC boosted its stake in Fluidigm Corporation by 4.2% in the first quarter. Stoneridge Investment Partners LLC now owns 25,293 shares of the medical research company’s stock worth $144,000 after buying an additional 1,013 shares during the period. American International Group Inc. boosted its stake in Fluidigm Corporation by 7.1% in the first quarter. American International Group Inc. now owns 17,907 shares of the medical research company’s stock worth $102,000 after buying an additional 1,187 shares during the period. Falcon Point Capital LLC boosted its stake in Fluidigm Corporation by 3.1% in the first quarter. Falcon Point Capital LLC now owns 40,661 shares of the medical research company’s stock worth $231,000 after buying an additional 1,238 shares during the period. Finally, Geode Capital Management LLC boosted its stake in Fluidigm Corporation by 1.5% in the first quarter. Geode Capital Management LLC now owns 218,321 shares of the medical research company’s stock worth $1,242,000 after buying an additional 3,311 shares during the period. Institutional investors own 91.41% of the company’s stock.
Shares of Fluidigm Corporation (NASDAQ FLDM) opened at 3.64 on Friday. The firm’s market capitalization is $107.07 million. The firm’s 50-day moving average is $3.70 and its 200 day moving average is $4.85. Fluidigm Corporation has a 52 week low of $2.52 and a 52 week high of $9.65.
Fluidigm Corporation (NASDAQ:FLDM) last posted its quarterly earnings data on Thursday, August 3rd. The medical research company reported ($0.58) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.60) by $0.02. The business had revenue of $23.90 million during the quarter, compared to the consensus estimate of $23.50 million. Fluidigm Corporation had a negative return on equity of 121.04% and a negative net margin of 74.05%. The company’s revenue was down 15.2% compared to the same quarter last year. During the same period in the prior year, the company earned ($0.63) earnings per share. On average, equities analysts forecast that Fluidigm Corporation will post ($2.19) earnings per share for the current year.
TRADEMARK VIOLATION WARNING: “Public Employees Retirement System of Ohio Holds Position in Fluidigm Corporation (FLDM)” was originally posted by BNB Daily and is owned by of BNB Daily. If you are accessing this article on another publication, it was copied illegally and republished in violation of United States & international trademark & copyright laws. The legal version of this article can be read at https://www.baseball-news-blog.com/2017/08/19/fluidigm-corporation-fldm-stake-held-by-public-employees-retirement-system-of-ohio-updated.html.
A number of analysts recently commented on the stock. Zacks Investment Research upgraded shares of Fluidigm Corporation from a “sell” rating to a “hold” rating in a research note on Thursday, June 1st. ValuEngine cut shares of Fluidigm Corporation from a “sell” rating to a “strong sell” rating in a research note on Friday, June 2nd.
In other news, Director Evan/ Fa Jones sold 10,900 shares of the stock in a transaction that occurred on Wednesday, June 7th. The stock was sold at an average price of $4.54, for a total value of $49,486.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Levin Capital Strategies, L.P. acquired 4,003,129 shares of the firm’s stock in a transaction dated Thursday, August 10th. The stock was purchased at an average cost of $3.30 per share, with a total value of $13,210,325.70. The disclosure for this purchase can be found here. Insiders bought 4,106,038 shares of company stock valued at $13,496,083 over the last three months. Corporate insiders own 4.70% of the company’s stock.
Fluidigm Corporation Company Profile
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.
Receive News & Ratings for Fluidigm Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm Corporation and related companies with MarketBeat.com's FREE daily email newsletter.